Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 67, Issue 1, 2007, Pages 187-195

  Gondi, Vinai ^a   Bradley, Kristin ^a   Mehta, Minesh ^a   Howard, Andy ^a   Khuntia, Deepak ^a   Ritter, Mark ^a   Tomé, Wolfgang ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Computed tomography; Esophageal cancer; Non small cell lung cancer; Positron emission tomography; Radiotherapy planning

Indexed keywords

COMPUTERIZED TOMOGRAPHY; MEDICAL IMAGING; PATIENT TREATMENT; RADIOTHERAPY; TUMORS;

ESOPHAGEAL CANCER; NON-SMALL-CELL LUNG CANCER; RADIOTHERAPY PLANNING;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; ESOPHAGUS CANCER; HUMAN; LUNG NON SMALL CELL CANCER; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT PLANNING; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; ESOPHAGEAL DISEASES; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33845671751     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.09.033     Document Type: Article

References (36)

1. Nestle U., Walter K., Schmidt S., et al. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: High impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 44 (1999) 593-597
2. Mac Manus M.P., Hicks R.J., Ball D.L., et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma. Cancer 92 (2001) 886-895
3. 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: A prospective study. Int J Radiat Oncol Biol Phys 52 (2002) 339-350
4. Bradley J., Thorstad W.L., Mutic S., et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59 (2004) 78-86
5. 18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially respectable non-small-cell lung cancer. J Clin Oncol 23 (2005) 8348-8356
6. Pieterman R.M., van Putten J.W.G., Meuzelaar J.J., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343 (2000) 254-261
7. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16 (1998) 2142-2149
8. Gould M.K., Kuschner W.G., Rydzak C.E., et al. Test performance for positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer. Ann Intern Med 139 (2003) 879-892
9. Toloza E.M., Harpole L., and McCrory D.C. Noninvasive staging of non-small cell lung cancer: A review of the current evidence. Chest 123 (2003) 137S-146S
10. Dwamema B.A., Sonnad S.S., Angobaldo J.O., et al. Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. Radiology 213 (1999) 530-536
11. Choi J.Y., Lee K.H., Shim Y.M., et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med 41 (2000) 808-815
12. Tio T.L., Coene P.P., Schouwink M.H., et al. Esophagogastric carcinoma: Preoperative TNM classification with endosonography. Radiology 173 (1989) 411-417
13. Massari M., Cioffi U., De Simone M., et al. Endoscopic ultrasonography for preoperative staging of esophageal carcinoma. Surg Laparosc Endosc 7 (1997) 162-165
14. Block M.I., Patterson G.A., Sundaresan R.S., et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 64 (1997) 770-776
15. Flamen P., Lerut A., Van Cutsem E., et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18 (2000) 3202-3210
16. Lerut T., Flamen P., Ectors N., et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 232 (2000) 743-752
17. Wallace M.B., Nietert P.J., Earle C., et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: Computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg 74 (2002) 1026-1032
18. Kato H., Kuwano H., Nakajima M., et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 94 (2002) 921-928
19. Erdi Y., Rosenzweig K., Erdi A., et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 62 (2002) 51-60
20. Giraud P., Grahek D., Montravers F., et al. CT and 18F-deoxyglucose (FDG) image fusion or optimization on conformal radiotherapy in lung cancers. Int J Radiat Oncol Biol Phys 49 (2001) 1249-1257
21. Vanuystel L., Vansteenkiste J., Sroobants S., et al. The impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 55 (2000) 317-324
22. Moureau-Zabotto L., Touboul E., Lerouge D., et al. Impact of CT and 18F-deoxyglucoase positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys 63 (2005) 340-345
23. Scarfone C., Lavely W.C., Cmelak A.J., et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 45 (2004) 543-552
24. Schwartz D.L., Ford E.C., Rajendran J., et al. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation. Head Neck 27 (2005) 478-487
25. Heron D.E., Andrade R.S., Flickinger J., et al. Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: A brief technical report. Int J Radiat Oncol Biol Phys 60 (2004) 1419-1424
26. Bettinardi V., Danna M., Savi A., et al. Performance evaluation of the new whole-body PET/CT scanner: Discovery ST. Eur J Nucl Med Mol Imag 31 (2004) 867-881
27. Wang D., Schultz C.J., Jursinic P.A., et al. Initial experience of FDG-PET/CT guided IMRT of head and neck carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 143-151
28. Nestle U., Kremp S., Schaefer-Schuler A., et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 46 (2005) 1342-1348
29. Chetty I.J., Fernando M., Kessler M.L., et al. Monte Carlo-based lung cancer treatment planning incorporating PET-defined target volumes. J Appl Med Phys 6 (2005) 65-76
30. Black Q.C., Grills I.S., Kestin L.L., et al. Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys 60 (2004) 1272-1282
31. Daisne J.F., Sibomana M., Bol A., et al. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: Influence of reconstruction algorithms. Radiother Oncol 69 (2003) 247-250
32. Nehmeh S.A., Erdi Y.E., Ling C.C., et al. Effect of respiratory gating on reducing lung motion artifacts in PET imaging of lung cancer. Med Phys 29 (2002) 366-371
33. Nehmeh S.A., Erdi Y.E., Pan T., et al. Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys 31 (2004) 3179-3186
34. Zhang T., Pyzalski R., Jaskowiak C., Tomé W., Mackie T., and Paliwal B. Deformable fusion of 4D PET images. Med. Phys 32 (2005) 2082-2086
35. Flanagan F.L., Dehdashti F., Siegel B.A., et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. Am J Roentgenol 168 (1997) 417-424
36. Vrieze O., Haustermans K., De Wever W., et al. Is there a role for FDG-PET in radiotherapy planning in esophageal carcinoma?. Radiother Oncol 73 (2004) 269-275